Inpharma Weekly

, Volume 1365, Issue 1, pp 4–4 | Cite as

Antibacterials to treat resistant pathogens could be approved based on limited phase III study data,

News item
  • 4 Downloads

Keywords

Development Programme Limited Range Great Benefit Study Data Drug Product 

Copyright information

© Adis International Ltd 2002

Personalised recommendations